Targeting DNA Damage Response and Repair as a Therapeutic Strategy for Ovarian Cancer. [electronic resource]
- Hematology/oncology clinics of North America 12 2018
- 997-1010 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
1558-1977
10.1016/j.hoc.2018.07.006 doi
Antineoplastic Agents--adverse effects Carcinoma, Ovarian Epithelial--drug therapy DNA Damage DNA Repair Female Humans Ovarian Neoplasms--drug therapy Poly(ADP-ribose) Polymerases--genetics